Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome

NCT07168434 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

406

Enrollment

INDUSTRY

Sponsor class

Conditions

IBS (Irritable Bowel Syndrome)
IBS-D (Diarrhea-predominant)
IBS, Mixed Symptoms

Interventions

DRUG: Saccharomyces Boulardii 250 MG
DRUG: Placebo 250 mg

Sponsor

Biocodex